基于MiRNA相关基因的分子亚型和预后模型来预测肺腺癌的预后

Yuxi Wei1, Wei Zhong1, Yalan Bi2

  • 1Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100000, China.

Current medicinal chemistry
|September 15, 2023
PubMed
概括

这项研究使用microRNA (miRNA) 相关基因确定肺腺癌 (LUAD) 的分子亚型,帮助预后和治疗决策. 这些发现突出了特定的亚型.